Immutep Advances IMP761 Manufacturing

3 years ago

SYDNEY, AUSTRALIA, Dec. 16, 2021 (GLOBE NEWSWIRE) --  Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology…

electroCore, Inc. Provides Update on Global Distribution Partners

3 years ago

ROCKAWAY, NJ, Dec. 16, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced…

Histogen Announces $3.5 Million Private Placement

3 years ago

SAN DIEGO, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage company focused on developing potential first-in-class…

Vaxart to Test Cross-Reactivity of its COVID-19 Oral Tablet Vaccine Against Omicron

3 years ago

Cross-reactivity will be assessed using samples from Phase II clinical participants and in a parallel animal challenge study Oral tablet’s…

Bolt Biotherapeutics Appoints Nicole Onetto, M.D., to Board of Directors

3 years ago

REDWOOD CITY, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new…

Marrone Bio Optimizes Bioherbicide with New Bacteria Strains, Accelerates Product Development to Enter $27 Billion Herbicide Market¹

3 years ago

DAVIS, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), has acquired exclusive rights to high-performing…

Arcutis Appoints Mas Matsuda as General Counsel and Corporate Secretary

3 years ago

Mas Matsuda Esq. Mas Matsuda Joins Arcutis as General Counsel and Corporate Secretary WESTLAKE VILLAGE, Calif., Dec. 16, 2021 (GLOBE…

Corcept Therapeutics Announces Preliminary Results of Previously Announced Tender Offer

3 years ago

MENLO PARK, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) (“Corcept”), a commercial-stage company engaged in…

BriaCell Announces Insiders’ Intention to Purchase up to 10% of Public Market Securities

3 years ago

Insiders intend to acquire up to approximately 10% of BriaCell’s basic common shares, or 1.59 million sharesCorporate buyback program will…

COMPASS Pathways announces changes in Executive Team

3 years ago

Matthew Owens appointed General Counsel and Chief Legal Officer; Lars Wilde, Chief Business Officer and Co-founder, to move into senior…